Status:
COMPLETED
Impact of Severe Intraoperative Hyperglycemia on Infection Rate After Elective Intracranial Interventions
Lead Sponsor:
Burdenko Neurosurgery Institute
Conditions:
Hyperglycemia
Craniotomy
Eligibility:
All Genders
18+ years
Brief Summary
Severe intraoperative hyperglycemia (SIH) is recognized as one of the important risk factors for the increasing of the postoperative infections rate, which can negatively affect the final outcome of s...
Eligibility Criteria
Inclusion
- Adult patients (\>18 years) scheduled for elective intracranial (open or endoscopic) intervention.
Exclusion
- Diagnosis of infection (local or systemic) in preoperative period; urgent intervention.
Key Trial Info
Start Date :
October 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
514 Patients enrolled
Trial Details
Trial ID
NCT04285359
Start Date
October 28 2020
End Date
April 1 2021
Last Update
April 30 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sapienza University of Rome
Roma, Italy
2
Federal State Autonomous Institution "N .N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Healthcare of the Russian Federation
Moscow, Russia, 125047